Esco CelCradle Tidal-Flow Single-Use Bioreactor

Overview

The Esco CelCradle is a single-use, tidal-flow bioreactor engineered for scalable, serum-free, adherent cell culture under controlled physiological conditions. Unlike conventional stirred-tank or microcarrier-based systems, the CelCradle operates on a passive tidal motion principle—driven by cyclic compression and decompression of an external peristaltic pump–actuated bellows—to generate gentle, bidirectional medium displacement within the sterile, pre-assembled PET vessel. This mechanism establishes a dynamic gas–liquid interface across the high-surface-area BioNOC™ microcarrier matrix, enabling continuous oxygen transfer and nutrient replenishment without shear stress–induced damage. Designed for seamless transition from discovery through clinical manufacturing, the system supports process intensification in autologous and allogeneic cell therapy workflows—including mesenchymal stromal cells (MSCs), HEK293T, and other anchorage-dependent lines—while eliminating manual passaging, open handling, and vessel-to-vessel transfer.

Key Features

• Pre-sterilized, gamma-irradiated PET bioreactor vessels—ready-to-use out of the package with no pre-cleaning or autoclaving required
• Tidal-flow hydrodynamics optimized for low-shear, high-efficiency mass transfer; eliminates need for impellers, spargers, or internal sensors
• Modular platform supporting 1–4 parallel vessels (5–500 L working volume range) with independent temperature control (22–40 °C)
• Integrated BioNOC™ carriers providing >10,000 cm²/m² specific surface area—enabling >10⁷ cells/mL densities without enzymatic detachment
• Automated harvest protocol: integrated medium exchange, cell detachment (via controlled trypsin perfusion or EDTA rinse), and collection into sterile bags
• Compact footprint (<0.5 m² per 50 L unit)—reducing cleanroom space requirements by >85% versus equivalent T-flask or roller-bottle operations

Sample Compatibility & Compliance

The CelCradle is validated for use with human and veterinary primary cells, immortalized lines (e.g., CHO-K1, Vero, MDCK), and therapeutic cell types including MSCs, dendritic cells, and CAR-T progenitors. All components comply with USP Class VI biocompatibility standards. The gamma-irradiated PET vessel meets ISO 10993-5 cytotoxicity and ISO 10993-10 sensitization requirements. Process documentation supports adherence to ICH Q5A(R2), FDA Guidance for Human Somatic Cell Therapy (2020), and EMA CHMP Guideline on Quality, Non-Clinical and Clinical Requirements for Investigational Advanced Therapy Medicinal Products (ATMPs). System operation logs and parameter history are structured to align with 21 CFR Part 11 audit trail expectations when paired with compliant LIMS or MES integration.

Software & Data Management

Control is managed via Esco’s proprietary CelCradle Control Station—a touchscreen HMI running real-time PID-regulated temperature and tidal cycle monitoring. Each vessel logs timestamped records of cycle frequency (0.1–6 cycles/hour), dwell time, medium volume, and thermal profile. Exportable CSV and PDF reports include full session metadata, alarm logs, and user action timestamps. Optional OPC UA connectivity enables integration with enterprise data infrastructure (e.g., DeltaV, Siemens Desigo, LabVantage) for centralized batch record compilation and electronic signature support per ALCOA+ principles.

Applications

• Scalable expansion of adherent therapeutic cells for Phase I–III clinical trials and commercial manufacturing
• Vaccine production: propagation of virus-permissive cells (e.g., MRC-5, Vero) for inactivated or viral vector platforms
• Exosome and extracellular vesicle (EV) harvesting—leveraging high-density cultures and synchronized medium exchange
• Process development and comparability studies between 2D static culture and 3D dynamic bioreactor systems
• Regulatory filing support: generation of GMP-aligned process characterization data for IND/IMPD submissions

FAQ

Is the CelCradle compatible with serum-free and chemically defined media?
Yes—the system has been qualified with multiple commercial serum-free formulations for MSCs and HEK293 lines, including StemPro® MSC SFM, X-VIVO™ 15, and FreeStyle™ 293 Expression Medium.
Can the BioNOC™ carriers be reused or autoclaved?
No—BioNOC™ carriers are supplied pre-loaded and gamma-sterilized within the PET vessel. Reuse or re-sterilization is not supported per manufacturer validation.
What level of operator training is required to run the system?
Minimal training is needed: standard operating procedures require <2 hours for new users; all critical parameters are pre-configured and locked per application protocol.
Does Esco provide regulatory support documentation?
Yes—full DQ/IQ/OQ protocols, vendor qualification dossiers, and risk assessments (per ISO 14971) are available under NDA to qualified customers.
How does the CelCradle compare to traditional microcarrier bioreactors in terms of scalability?
Unlike stirred-tank microcarrier systems requiring complex impeller optimization and foam control, the CelCradle achieves linear scale-up across 5 L to 500 L volumes using identical tidal dynamics—eliminating requalification needs between scales.